ARTIVION INC (AORT) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:AORT - US2289031005 - Common Stock
AORT Key Statistics, Chart & Performance
The current stock price of AORT is 45.685 USD. In the past month the price decreased by -1.81%. In the past year, price increased by 49.23%.
AORT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.7 | 223.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.48 | 209.01B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.03 | 144.46B | ||
| SYK | STRYKER CORP | 27.6 | 138.99B | ||
| BDX | BECTON DICKINSON AND CO | 14.2 | 58.45B | ||
| IDXX | IDEXX LABORATORIES INC | 55.91 | 56.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.55 | 50.03B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.91 | 39.54B | ||
| RMD | RESMED INC | 25.22 | 36.44B | ||
| DXCM | DEXCOM INC | 37.55 | 27.24B | ||
| PODD | INSULET CORP | 64.28 | 20.67B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.68 | 18.73B |
Related stock screener links
About AORT
Company Profile
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
Company Info
ARTIVION INC
1655 Roberts Boulevard N W
Kennesaw GEORGIA US
Employees: 1600
Phone: 17704193355
ARTIVION INC / AORT FAQ
Can you describe the business of ARTIVION INC?
Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,600 full-time employees. The firm is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company has four major product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Its Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. Its Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include its BioGlue Surgical Adhesive products.
What is the stock price of ARTIVION INC today?
The current stock price of AORT is 45.685 USD. The price increased by 2.46% in the last trading session.
What is the dividend status of ARTIVION INC?
AORT does not pay a dividend.
How is the ChartMill rating for ARTIVION INC?
AORT has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for AORT stock?
13 analysts have analysed AORT and the average price target is 52.75 USD. This implies a price increase of 15.46% is expected in the next year compared to the current price of 45.685.
Can you provide the upcoming earnings date for ARTIVION INC?
ARTIVION INC (AORT) will report earnings on 2026-02-23, after the market close.
AORT Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to AORT. When comparing the yearly performance of all stocks, AORT is one of the better performing stocks in the market, outperforming 87.44% of all stocks.
AORT Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AORT. AORT has an average financial health and profitability rating.
AORT Financial Highlights
Over the last trailing twelve months AORT reported a non-GAAP Earnings per Share(EPS) of -0.26. The EPS decreased by -85.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.06% | ||
| ROE | -2.08% | ||
| Debt/Equity | 0.5 |
AORT Forecast & Estimates
13 analysts have analysed AORT and the average price target is 52.75 USD. This implies a price increase of 15.46% is expected in the next year compared to the current price of 45.685.
For the next year, analysts expect an EPS growth of 144.67% and a revenue growth 12.7% for AORT